ZQU

Zosuquidar

Created:	2018-02-05
Last modified:	2018-02-21

Find Related PDB Entry
3 entries where ZQU is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	70
Chiral Atom Count	3
Bond Count	76
Aromatic Bond Count	23

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Zosuquidar
Formula	C₃₂ H₃₁ F₂ N₃ O₂
Molecular Weight	527.604
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	O[CH](COc1cccc2ncccc12)CN3CCN(CC3)C4c5ccccc5[CH]6[CH](c7ccccc47)C6(F)F
SMILES	OpenEye OEToolkits	2.0.6	c1ccc2c(c1)C(c3ccccc3C4C2C4(F)F)N5CCN(CC5)CC(COc6cccc7c6cccn7)O
Canonical SMILES	CACTVS	3.385	O[C@@H](COc1cccc2ncccc12)CN3CCN(CC3)C4c5ccccc5[C@@H]6[C@H](c7ccccc47)C6(F)F
Canonical SMILES	OpenEye OEToolkits	2.0.6	c1ccc2c(c1)[C@@H]3[C@@H](C3(F)F)c4ccccc4C2N5CCN(CC5)C[C@H](COc6cccc7c6cccn7)O
InChI	InChI	1.03	InChI=1S/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31-/m1/s1
InChIKey	InChI	1.03	IHOVFYSQUDPMCN-DBEBIPAYSA-N

Drug Info: DrugBank

DrugBank ID	DB06191
Name	Zosuquidar
Groups	investigational
Description	Zosuquidar is a compound of antineoplastic drug candidates currently under development. It is now in "Phase 3" of clinical tests in the United States. Its action mechanism consists of the inhibition of P-glycoproteins; other drugs with this mechanism include tariquidar and laniquidar.
Synonyms	Zosuquidar Zosuquidar trihydrochloride
Indication	Investigated for use/treatment in leukemia (myeloid) and myelodysplastic syndrome.
Categories	Benzocycloheptenes Drug Resistance, Multiple Heterocyclic Compounds, Fused-Ring P-glycoprotein inhibitors
CAS number	167354-41-8

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682